What is Bio-Gate AG Price-to-Operating-Cash-Flow?
As of today (2024-06-20), Bio-Gate AG's share price is €1.05.
Bio-Gate AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.12. Hence, Bio-Gate AG's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Bio-Gate AG's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, Bio-Gate AG's highest Price-to-Operating-Cash-Flow Ratio was 74.53. The lowest was 28.30. And the median was 47.36.
Bio-Gate AG's Cash Flow from Operations per share for the
six
months ended in Dec. 2023 was €0.01.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.12.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -8.60% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -7.90% per year.
During the past 13 years, Bio-Gate AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 63.00% per year. The lowest was -70.40% per year. And the median was -8.80% per year.
Bio-Gate AG Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Bio-Gate AG's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Gate AG Price-to-Operating-Cash-Flow Chart
|
Bio-Gate AG Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
- |
- |
- |
- |
|
Bio-Gate AG Semi-Annual Data
|
|
Jun14 |
Dec14 |
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Bio-Gate AG's Price-to-Operating-Cash-Flow
For the Medical Instruments & Supplies subindustry, Bio-Gate AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Gate AG's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio-Gate AG's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Bio-Gate AG's Price-to-Operating-Cash-Flow falls into.
Bio-Gate AG Price-to-Operating-Cash-Flow Calculation
Bio-Gate AG's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 1.05 | / | -0.118 |
| = | |
Bio-Gate AG's Share Price of today is €1.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bio-Gate AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Bio-Gate AG (XTER:BIG1) Business Description
Traded in Other Exchanges
Address
Neumeyerstraße 28-34, Nürnberg, DEU
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Executives
Bio-Gate AG (XTER:BIG1) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:BIG1 has been successfully added to your